Strange encounters in Diagnostic Imaging
August 20th 2010Dr. Brian Witcombe, a consultant radiologist at Gloucestershire Royal Hospital, collaborated with Dan Meyer, executive director of the Sword Swallowers' Association International on the study. Interviews with experienced sword swallowers revealed that lower chest pain, often lasting days, followed some performances.
End of Life: A Primary Care "Road Less Traveled"
August 20th 2010In many instances, our patients receive invasive and aggressive subspecialty care at or near the end of life. Such care can become burdensome and painful without a favorable outcome. As advocates for our patients, we must ensure that their pain, shortness of breath, and other bothersome symptoms are alleviated, thus leading to a “good death.”
Substance Abuse and HIV: Treatment Challenges
August 13th 2010Substance abuse, especially injection drug abuse, is often associated with chronic infectious diseases, including HIV infection, hepatitis B, hepatitis C, and tuberculosis. Delivery of effective treatment for these chronic conditions can be very challenging in patients who continue to abuse substances.
Prevention of Exercise-Related Injuries in Women: 7 Tips From the CDC
August 4th 2010Your patient is a previously sedentary, overweight 39-year-old woman who has recently taken up running. She now presents with pain and swelling anteroinferior to the lateral malleolus after she twisted her ankle while running on uneven pavement 1 day earlier. Your diagnosis: an uncomplicated lateral ankle sprain.
Whither Goes Evidence-Based Medicine?
August 3rd 2010Discussions that focus on health care costs have created a specialized vocabulary, such as comparative effectiveness research. The concept undergirding this field may be defined as “the conduct and synthesis of research comparing the benefits and harms of different interventions and strategies to prevent, diagnose, treat, and monitor health conditions in ‘real world’ settings.”
Health Care Reform: Perspectives on Cost Containment
June 30th 2010In the December 14, 2009, issue of The New Yorker magazine, Atul Gawande observed, “Cost is the specter haunting health care reform.” The idea (or better, mantra?) of cost as central to health care’s reform is not new but is surely a topic that demands this generation’s consideration. Most of the economic debate has been general, looking at national “bottom lines” rather than focusing on the “dollars and cents” of individual diseases. Let’s take a sobering look at rising costs in the context of specific diseases, beginning with psoriasis.